HomeDoctor Raises €3,7m Series A Funding Led by Cogito Capital Partners

October 1, 2020

HomeDoctor is a Warsaw and Amsterdam-based digital healthcare provider.

HomeDoctor announced a €3,7m Series A funding round led by Cogito Capital Partners with participation from the Company’s founders. HomeDoctor, founded in 2016, is a leader in the Polish market in providing online medical consultations and delivery of healthcare services to patients’ homes. The Company is operating as a b2b2c and a b2c medical services platform that enables delivery of both, online and phone consultations (telemedicine channel) and booking a doctor appointment (home visit).

HomeDoctor is also a key partner for the largest medical centers and insurers in Poland. They developed an effective and patient-centric healthcare model that combines complementary digital and physical consultations. HomeDoctor’s services are available online as well as through a dedicated mobile app (connecting doctors and patients). For home-visits business, the Company uses geo-location technology, to ensure that the nearest available doctor is dispatched to a patient, which allows for the delivery of a home visit within 1 hour of wait time. This feature, combined with over 200 GPs dedicated to home-visits, gives HomeDoctor a unique competitive advantage and a clear leadership position in Poland. The Company works with over 350 doctors (GPs as well as 16 different specializations) who call on patients across Poland. With the onset of the COVID-19 pandemic, the Company recorded an unprecedented growth in demand, especially in teleconsultations.

Also, the Q3 2020 data shows a dynamic growth in the number of home visits. This model gives the Company a competitive advantage and enables for patient-centric innovations. HomeDoctor’s ambitious growth strategy focuses on further product development – telemedicine consultation service (telco/video), both in the b2b and b2b2c models, expansion of home visits, and an integrated online pharmacy as well as tailored offerings for enterprise customers. HomeDoctor will use the investment to continue the growth of its operations in Poland, building its team and capacity in order to further expand geographically and build strategic partnerships aimed at scaling-up the Company’s offering and market reach. The Company plans on expanding its services to other European countries, building on growing adoption of telemedicine, regulatory changes, and developments in digital healthcare across Europe. Recent regulatory and reimbursement changes allow digital healthcare providers to be part of the publicly funded healthcare systems and thus increase access to highly competent and experienced medical professionals in the European countries.

The team behind HomeDoctor comprises of serial entrepreneurs and business executives, who have successfully built and scaled both enterprise and consumer-focused businesses. Szymon Horaczuk, the Founder and CEO of HomeDoctor said:

“Home Doctor’s mission is to transform the traditional healthcare model challenged by accessibility issues and deliver healthcare services to consumers in a seamless, patient-centric way. We are delighted to have Cogito on board, to support our plans and strengthen our capacity to execute our ambitious growth and expansion strategy”. Sylwester Janik, General Partner at Cogito said: “We are excited to partner with Szymon and his team to support HomeDoctor’s product and market expansion plans. The Company’s offering meets patients’ needs and preferences for affordable and accessible healthcare services, conveniently delivered online and directly to their homes, and is a game-changer in the healthcare industry”.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”